Background/Aims: Craniosynostosis, the premature fusion of cranial sutures, is a common congenital defect. In vivo models for studying cranial suture biology impose inherent restrictions on tissue accessibility and manipulation. The present study was performed to investigate the utility of the renal capsule assay in overcoming these limitations and providing a reproducible model system for studying cranial suture morphogenesis and fate. Materials and Methods: The posterior frontal suture, which fuses physiologically, and the coronal and sagittal sutures, which remain patent, were dissected from postnatal and embryonic mouse calvaria and placed under the renal capsule of syngeneic recipient mice (n = 72 in total). Sutures were harvested from 1–14 days after transplantation for histological and morphometric analysis. Suture transplants were compared with nonmanipulated sutures at equivalent developmental stages. The derivation of cells associated with the growing transplants was analyzed using β-actin-GFP (green fluorescent protein) transgenic mice. Results: Sutures transplanted under the renal capsule maintained normal suture morphology and fate with the posterior frontal suture fusing and the coronal and sagittal sutures remaining patent. In posterior frontal suture transplants, the fusion process mimicked in vivo suture fusion with a delay of 1–2 days. In comparison to in vivo suture complexes, transplant thickness and trabeculation were significantly increased. In addition, we found that osteoblasts within the growing transplant were derived from the transplant itself rather than the host. Conclusion: The renal capsule supports the growth of cranial sutures. In this system transplanted sutures recapitulate the anatomical development and fate (fusion or patency) of cranial sutures in vivo. This model system will facilitate controlled ex vivo manipulations of both embryonic and postnatal sutures.

Keywords:
Coronal suture, Cranial suture, Craniosynostosis, Posterior frontal suture, Renal capsule, Sagittal suture, Mouse
1.
Aberg, T., R. Rice, D. Rice, I. Thesleff, J. Waltimo-Siran (2005) Chondrogenic potential of mouse calvarial mesenchyme. J Histochem Cytochem 53: 653–663.
2.
Bogden, A.E. (1985) The subrenal capsule assay (SRCA) and its predictive value in oncology. Ann Chir Gynaecol Suppl 199: 12–27.
3.
Bogden, A.E., P.M. Haskell, D.J. LePage, D.E. Kelton, W.R. Cobb, H.J. Esber (1979) Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice. Exp Cell Biol 47: 281–293.
4.
Cohen, M.M. (1979) Craniosynostosis and syndromes with craniosynostosis: incidence, genetics, penetrance, variability, and new syndrome updating. Birth Defects Orig Art Ser 15: 13–63.
5.
Colnot, C.l., C. Lu, D. Hu, J.A. Helms (2004) Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol 269: 55–69.
6.
Cunha, G.R., B. Lung (1979) The importance of stroma in morphogenesis and functional activity of urogenital epithelium. In Vitro 15: 50–71.
7.
Donahoe, P.K., I. Krane, A.E. Bogdén, S. Kamagata, G.P. Budzik (1984) Subrenal capsule assay to test the viability of parenterally delivered müllerian inhibiting substance. J Pediatr Surg 19: 863–869.
8.
Dufour, J.M., R.V. Rajotte, M. Zimmerman, A. Rezania, T. Kin, D.E. Dixon, G.S. Korbutt (2005) Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng 11: 1323–1331.
9.
Ferguson, C.A., A.S. Tucker, K. Heikinheimo, M. Nomura, P. Oh, E. Li, P.T. Sharpe (2001) The role of effectors of the activin signalling pathway, activin receptors IIA and IIB, and Smad2, in patterning of tooth development. Development 128: 4605–4613.
10.
Ghali, G.E., D.P. Sinn, S. Tantipasawasin (2002) Management of nonsyndromic craniosynostosis. Atlas Oral Maxillofac Surg Clin North Am 10: 1–41.
11.
Gurevich, O., A. Vexler, G. Marx, T. Prigozhina, L. Levdansky, S. Slavin, I. Shimeliovich, R. Gorodetsky (2002) Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. Tissue Eng 8: 661–672.
12.
Ignelzi, M.A., W. Wang, A.T. Young (2003) Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. J Bone Miner Res 18: 751–759.
13.
Jiang, X., S. Iseki, R.E. Maxson, H.M. Sucov, G.M. Morriss-Kay (2002) Tissue origins and interactions in the mammalian skull vault. Dev Biology 241: 106–116.
14.
Kim, H.J., D.P. Rice, P.J. Kettunen, I. Thesleff (1998) FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125: 1241–1251.
15.
Kim, J.Y., S.W. Cho, H.J. Hwang, M.J. Lee, J.M. Lee, J. Cai, S.H. Choi, C.K. Kim, H.S. Jung (2007) Evidence for expansion-based temporal BMP4/NOGGIN interactions in specifying periodontium morphogenesis. Cell Tissue Res 330: 123–132.
16.
Lajeunie, E., M. Le Merrer, C. Bonaïti-Pellie, D. Marchac, D. Renier (1995) Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet 55: 500–504.
17.
Lee, S.W., K.Y. Choi, J.Y. Cho, S.H. Jung, K.B. Song, E.K. Park, J.Y. Choi, H.I. Shin, S.Y. Kim, K.M. Woo, J.H. Baek, S.H. Nam, Y.J. Kim, H.J. Kim, H.M. Ryoo (2006) TGF-beta2 stimulates cranial suture closure through activation of the Erk-MAPK pathway. J Cell Biochem 98: 981–991.
18.
Lenton, K.A., R.P. Nacamuli, D.C. Wan, J.A. Helms, M.T. Longaker, P.S. Gerald (2005) Cranial suture biology. Curr Top Dev Biol 66: 287–328.
19.
Marchac, D., D. Renier (1989) Craniosynostosis. World J Surg 13: 358–365.
20.
Markens, I.S. (1975) Embryonic development of the coronal suture in man and rat. Acta Anat 93: 257–273.
21.
Mooney, M.P., H.W. Losken, A.M. Moursi, J.M. Shand, G.M. Cooper, C. Curry, L. Ho, A.M. Burrows, E.J. Stelnicki, J.E. Losee, L.A. Opperman, M.I. Siegel (2007) Postoperative anti-TGF-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. J Craniofac Surg 18: 336–346.
22.
Morio, I. (1985) Recombinant study of the mouse molar cervical loop and dental papilla by renal transplantation. Arch Oral Biol 30: 557–561.
23.
Most, D., J.P. Levine, J. Chang, J. Sung, J.G. McCarthy, S.A. Schendel, M.T. Longaker (1998) Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg 101: 1431–1440.
24.
Ogle, R.C. (2000) Craniofacial skeletal morphogenesis in vitro. Methods Mol Biol 136: 55–59.
25.
Oka, S., K. Oka, X. Xu, T. Sasaki, P. Bringas, Y. Chai (2007) Cell autonomous requirement for TGF-beta signaling during odontoblast differentiation and dentin matrix formation. Mech Devel 124: 409–415.
26.
Opperman, L.A. (2000) Cranial sutures as intramembranous bone growth sites. Dev Dyn 219: 472–485.
27.
Opperman, L.A., C.R. Fernandez, S. So, J.T. Rawlins (2006) Erk1/2 signaling is required for TGF-beta 2-induced suture closure. Dev Dyn 235: 1292–1299.
28.
Posnick, J.C. (2000) Craniofacial syndromes and anomalies in children and young adults. Philadelphia, W.B. Saunders.
29.
Richtsmeier, J.T., L.L. Baxter, R.H. Reeves (2000) Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn 217: 137–145.
30.
Sahar, D.E., M.T. Longaker, N. Quarto (2005) Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev Biol 280: 344–361.
31.
Schneider, R.A., D. Hu, J.A. Helms (1999) From head to toe: conservation of molecular signals regulating limb and craniofacial morphogenesis. Cell Tissue Res 296: 103–109.
32.
Shum, L., X. Wang, A.A. Kane, G.H. Nuckolls (2003) BMP4 promotes chondrocyte proliferation and hypertrophy in the endochondral cranial base. Int J Dev Biol 47: 423–431.
33.
Song, H.M., D.E. Sahar, K.D. Fong, R.P. Nacamuli, T.D. Fang, J.A. Mathy, O.O. Aalami, S.M. Warren, M.T. Longaker (2004) In vitro murine posterior frontal suture fate is age-dependent: implications for cranial suture biology. Plast Reconstr Surg 113: 1192–1204.
34.
Stadler, J.A., W. Cortes, L.L. Zhang, C.C. Hanger, Gosain A.K. (2006) A reinvestigation of murine cranial suture biology: microcomputed tomography versus histologic technique. Plastic Reconstr Surg 118: 626–634.
35.
Thesleff, I. (1981) Use of organ culture techniques in craniofacial developmental biology. Proc Finn Dent Soc Suppl 77: 159–169.
36.
Vu, T.H., Y. Alemayehu, Z. Werb (2003) New insights into saccular development and vascular formation in lung allografts under the renal capsule. Mech Dev 120: 305–313.
37.
Whitaker, L.A., I.R. Munro, K.E. Salyer, I.T. Jackson, F. Ortiz-Monasterio, D. Marchac (1979) Combined report of problems and complications in 793 craniofacial operations. Plastic Reconstr Surg 64: 198–203.
38.
Wigglesworth, D.J. (1968) Formation and mineralisation of enamel and dentine by rat tooth germs in vitro. Exp Cell Res 49: 211–215.
39.
Wilkie, A.O., G.M. Morriss-Kay (2001) Genetics of craniofacial development and malformation. Nat Rev Genet 2: 458–468.
40.
Yoshida, T., L.A. Phylactou, J.B. Uney, I. Ishikawa, K. Eto, S. Iseki (2005) Twist is required for establishment of the mouse coronal suture. J Anat 206: 437–444.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.